Results per Page:
Overcoming immune evasion: a new combination therapy advances treatment for a rare metastatic eye cancer
From Dr. Shailender Bhatia, Dr. Natalie Miller and colleagues, Clinical Research Division
Dr. Shailender Bhatia receives the Lyn and Daniel Lerner Endowed Chair in Merkel Cell Carcinoma
A family’s generosity will fuel the search for new ways to treat an aggressive skin cancer
‘Getting the T’ on T cell populations in colorectal cancer
From the Peters and Phipps Labs, Public Health Sciences Division and CCSG
Fred Hutch Phase 1 Program director, Dr. John Thompson, retires
An immunotherapy champion, Thompson co-led the melanoma clinic for decades
New tools in the pipeline for treating immune cell disorders
From the Walter Lab, Translational Sciences & Therapeutics Division
Fred Hutch research shines at national oncology conference
Society for Immunotherapy of Cancer meeting features new discoveries on cancer-cell visualization, T-cell survival and new targets for solid tumors
New initiative bolsters Washington state life sciences
Fred Hutch researchers awarded over $4M in grants from the Washington Research Foundation
Location, location, location: where is key for CAR T-cell therapy
From the Walter lab, Translational Science and Therapeutics Division
Let’s give these CAR(T cell)s some pedals!
From Dr. Jacob Appelbaum, Fred Hutch Clinical Research Division and Seattle Children’s Therapeutics, Seattle Children’s Hospital
Dr. Lawrence Fong, new Fred Hutch immunotherapy director, talks about how the field has transformed oncology
In-house grant funding program will underpin efforts to advance therapies to clinical trials
$5.25M from the Kuni Foundation propels innovative adult oncology research
Grants will support research on tumor regression, immunotherapy access and better care for breast, liver and peritoneal malignancies
Safety and feasibility approved for new therapy to treat relapsed hematologic malignancies
From the Bleakley Lab, Translational Science & Therapeutics Division
Cost-effective device trains immune cells to kill tumor cells
From the Matthias Stephan Lab, Translational Science & Therapeutics Division
How a Black woman is coping with an ‘old white man’s disease’
Bladder cancer patient manages the stress of a disease where recurrence is common
Could a medicated foam make gene therapies more accessible?
In Nature Communications, Fred Hutch bioengineer Matthias Stephan, MD, PhD, reports latest effort to use innovative materials to improve immune-based therapies.